Product Wiki · Recalls · U.S. FDA — Device Enforcement

Baxter Novum IQ LVP INFUSION SYSTEM, REF 40700BAXUS — recall Z-1767-2025

U.S. FDA — Device Enforcement · United States · 2025-04-24 · Class I

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
U.S. FDA — Device Enforcement
Recall identifier
Z-1767-2025
Date of alert
2025-04-24
Country / jurisdiction
United States
Risk level
Class I
Risk type
recall
Brand
Baxter Healthcare Corporation
Product category
device
Product type
Devices
Reported risk: There is a potential for the Novum IQ LVP due to the potential for underinfusion following use of the "standby mode" feature or if the device is powered off with the set loaded.
Primary source: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?start_search=1&

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.